{"filing":{"accession_number":"0001658247-26-000044","cik":"0001658247","ticker":"CRNX","company_name":"Crinetics Pharmaceuticals, Inc.","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"crnx-20260618.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000044/crnx-20260618.htm"},"events":[{"id":12777,"run_id":11336,"accession_number":"0001658247-26-000044","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K Item 5.07 discloses the final voting results from Crinetics Pharmaceuticals' annual stockholder meeting held June 18, 2026, covering three proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents complete vote tallies (For, Against/Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.","company_name":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9727,"accession_number":"0001658247-26-000044","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from Crinetics Pharmaceuticals' annual stockholder meeting held June 18, 2026, covering three proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents complete vote tallies (For, Against/Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:51:56.535407+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9727,"accession_number":"0001658247-26-000044","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K Item 5.07 discloses the final voting results from Crinetics Pharmaceuticals' annual stockholder meeting held June 18, 2026, covering three proposals: election of three Class II directors, ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents complete vote tallies (For, Against/Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T20:51:56.535407+00:00","company_name":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","filing_date":"2026-06-22"}]}